Dynamk Capital

Dynamk Capital is a growth and venture fund based in New York, focusing on early and seed-stage investments in the life sciences sector. The firm seeks to partner with innovative companies developing cutting-edge tools and technologies essential for the discovery, development, and production of life-saving therapies. By investing in healthcare devices, supplies, and life science industrials, Dynamk Capital aims to support visionary entrepreneurs whose ideas are transforming therapeutic development, enhancing patient access, and lowering costs. The fund operates primarily in the United States, Europe, and Canada, targeting opportunities that align with its mission to advance the life sciences landscape.

Jessica Davis

Senior Associate

Daniella Kranjac

Founding Partner & Managing Director

Mario M. Kranjac

Co-Founder, Founding Partner and General Counsel

Sebastien Latapie

Principal

Gustavo Mahler

Managing Partner

Reinhard Vogt

Venture Partner

Past deals in Vermont

Vernal Biosciences

Venture Round in 2022
Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis.